Takeda Rare Disorders Digest
Takeda Rare Disorders Digest
Takeda
Takeda Rare Disorders Digest
Takeda
Rare Disorders Digest is a Takeda podcast series designed to inform the audience about different rare diseases, and help them understand current diagnostic and treatment modalities, and some of the challenges that clinicians and patients face today. Listeners will hear from medical experts and patient advocates as they share their insights into current care and describe their aspirations for the future. Disclosures: This podcast is made in partnership with Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd., with the registered office 8 Marina Boulevard #05-02, Marina Bay Financial Centre, Tower 1, Singapore 018981. This information is available to the public for information purposes only; it should not be used for diagnosing or treating a health problem or disease. It is not intended to substitute consultation with a healthcare provider. Please consult your healthcare provider for advice. Intended for a general audience outside the US and UK.
Also Available on
Available episodes
11
0
Latest episode
4 years ago
December 7, 2022
Podcast Privacy Information
Omny
Stats, Tracking, Dynamic Audio
Stats: This service collects and aggregates basic information about its listenership, like total download numbers and downloads by date or region.
Tracking: This service may track an individual listener's browsing habits across podcasts and websites. This is typically used to measure advertising conversions. Podbay does not collect any Tracking data.
Dynamic Audio: This service may insert dynamic audio (usually for targeted advertising) into episodes on a per-download or per-stream basis. This could be as basic as factoring in the date or the user's overall region, or when used with Tracking, could be based on more personal user data.
All content for Takeda Rare Disorders Digest is the property of Takeda and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podbay in any way.